The SARC Multidisciplinary Tumor Board (SMTB) provides innovative multidisciplinary discussion for adults and children with sarcoma at any stage of the disease.

The Tumor Board meets the 2nd Friday of every month at 12 pm CT.

For physicians: Submit Case

A Team of Experts

As the care of patients with cancer becomes increasingly complex and therapeutic options become more nuanced, the input of providers from different aspects of the care spectrum is more critical than ever for optimal decision making for patients. The SMTB provides a forum where a team of experts from a wide range of specialties meet for in-depth, evidence-based discussion of tumor diagnosis and management. Our monthly sarcoma tumor board meeting involves physicians specializing in sarcoma from surgical oncology, orthopedic oncology, medical oncology, radiation oncology, pediatric oncology, pathology, and radiology. 

All sarcoma patient cases discussed at the SMTB are recorded and are available for future educational reference. 

Patient cases may be presented by the physician at any step along the cancer journey: before any diagnostic procedure, before initial biopsy, before primary surgery, after primary surgery, at relapse, and/or in case of possible inclusion in a clinical trial. The board will have a secure portal through which the physician can submit an intake form describing the case, treatment so far, and what clinical question they wish to discuss.

Meet Our Co-Facilitators

Gina D’AMATO, MD

Dr. D’Amato is an Associate Professor of Medicine at the Sylvester Comprehensive Cancer Center at the University of Miami, where she serves as a sarcoma medical oncologist, assistant director of clinical research, and medical director of the Comprehensive Treatment Unit. In addition to her clinical service, she is also involved in clinical trials for GIST and other sarcomas and is co-director of the oncology pathway in a newly implemented curriculum for the University of Miami Miller School of Medicine.

Scott Okuno, MD

Dr. Scott Okuno is Professor of Oncology at Mayo Clinic in Rochester, Minnesota. He is a recognized expert in sarcoma and clinical research. Dr. Okuno has been the SARC Medical Officer since 2012. Dr. Okuno was appointed SARC Chief Medical Officer in September 2022, and he joined the SARC Board of Directors in October 2022.

Virtual Presentation and Review

SMTB will meet at regularly scheduled multidisciplinary virtual conferences to prospectively review individual sarcoma patients and discuss best management, keeping in mind that individual physicians are responsible for making the ultimate treatment decision. 

The value of SMTB is that it brings together many sarcoma experts across many institutions to discuss cases and provide insights that a single institutional tumor board would not be able to.

Individual physicians are responsible for making the request for the SMTB. Cases will be presented virtually by the submitting provider. Once you have submitted the form, the SMTB coordinator will schedule the case.

father, child, nurse

Support the Work

100% of SARC donations go directly to support program initiatives. The SARC Multidisciplinary Tumor Board provides physicians with multiple perspectives and expertise to help them develop the best treatment plan for their patients. Help us continue this program.

Case Submission Form for Physicians

The SARC Multidisciplinary Tumor Board meets the 2nd Friday of every month at 12 pm CT. Use this form to submit a request to discuss your sarcoma case. Please submit this form at least two weeks prior to the tumor board’s monthly meeting.

If your case submission is accepted, SMTB will require slides or x-rays. You do not need to provide those files now. Upon acceptance you will be contacted and asked to send additional materials via email. 

If you have any questions about this form or the submission process, please email Lindsey Overman at tumorboard@sarctrials.org.

Contact Information:

Case Information:

Please organize patient information into the following categories. Complete information will assist the tumor board chairs and committee members in selecting the cases.
Back to top